This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Preluent

Sanofi

Drug Names(s): XRP0673, RPR130673, FXV673

Description: Otamixaban in an injectable agent that directly and selectively inhibits the plasma coagulation Factor Xa.


Preluent News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug